CD274 and cancer: The lower avelumab uptake in the NCIN87 tumors when compared with spleen and lymph nodes results from the low to moderate levels of PD-L1 (44,000 PD-L1/cell) in NCIN87 cancer cells as determined in vitro (Figure 1).